Actively Recruiting
Cell Free DNA in Mature B-cell Lymphoma
Led by Ruijin Hospital · Updated on 2023-02-24
320
Participants Needed
1
Research Sites
217 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to assess whether plasma cell free DNA is an accurate tool that can early and dynamically inform on treatment outcome and an accessible source of tumor DNA to track tumor clonal evolution.
CONDITIONS
Official Title
Cell Free DNA in Mature B-cell Lymphoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Documented diagnosis of mature B-cell tumor according to WHO 2008 criteria
- 18 years or older
You will not qualify if you...
- Previous chemotherapy treatment
- Presence of other tumors
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ruijin hospital
Shanghai, Shanghai Municipality, China, 200025
Actively Recruiting
Research Team
W
Weili Zhao, MD，PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here